BeStock  
Markets › Compare › CAI vs GTLB

CAI vs GTLB

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
CAI · Caris Life Sciences$30.39 ▲ 7.39%
GTLB · Gitlab$51.50 ▲ 3.46%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

38577796116Oct 7, '25Apr 7, '26Oct 5, '26
  • CAI -3.8%
  • GTLB +11.6%

Head to head

MetricCAIGTLB
Price$30.39$51.50
Change today▲ 7.39%▲ 3.46%
Market cap$8.59B$8.58B
Return, 3 months+74.0%+58.0%
Return, year to date+12.6%+37.2%
Return, 1 year-7.4%+9.3%
P/E (TTM)81.7-160.9
P/B14.59.3
P/E percentile vs own 5y––
Dividend yield––
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)––
Gross margin––
Operating margin––
Net margin––
Return on equity––
Analyst target vs. price––
Analyst buy share––
RSI (14)6066
30-day volatility63.0%51.9%
Max drawdown, 1 year-55.8%-62.0%
Trend readStrong uptrendStrong uptrend
Analyst consensus––

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • CAI is the largest of the group by market value.
  • GTLB has returned the most over the past year.
  • GTLB carries the lowest trailing P/E.
  • GTLB has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top